For more than four decades ago, researchers began developing Vaginal contraceptive rings characterized by two guiding principles: the ability vaginal epithelium is made up of a layer of cells that line within the structure vaginal canal ingest the application of steroid ability of elastomers to release hormones at a virtually constant rate. Only two kinds of contraceptive vaginal rings (CVRs) it has been completed to market: NuvaRing, a combination ring that distributes etonogestrel (ENG) and ethinyl estradiol (EE), and Progering, a progesterone-releasing ring for nursing women. The main benefits CVRs are a type of efficacy (tablets are comparable to or slightly superior to), simple to use (no need to remember aa regular schedule), user control over initiation and removal, release rate that is practically constant allowing for flexibility low dosage, greater bioavailability, and excellent cycle control because of the integrated ring. CVRs can produce cervical bleeding and complaints, band expulsion is typical, the ring can During coitus, in addition vaginal implantation can be painful for certain women. CVRs are completely safe, efficacious, Women find it quite appealing, in conformity with studies discussed in this work. CVRs are without a doubt a novel, very efficient contraception for women, expanding their hormonal contraception options.
Cite this article:
Kunal M. Agavane, Sonal B. Ombase. Contraceptive Vaginal Ring: Nuvaring. Research Journal of Science and Technology. 2022; 14(1):73-6. doi: 10.52711/2349-2988.2022.00011
Kunal M. Agavane, Sonal B. Ombase. Contraceptive Vaginal Ring: Nuvaring. Research Journal of Science and Technology. 2022; 14(1):73-6. doi: 10.52711/2349-2988.2022.00011 Available on: https://rjstonline.com/AbstractView.aspx?PID=2022-14-1-11
1. Oshin Bansode Contraception 26 july; 2021,https://www.statpearls.com/ArticleLibrary/viewarticle/19940
2. Frans Jme Roumen. Review of the combined contraceptive vaginal ring, NuvaRing.National Center for Biotechnology Information journal. 2008; 4(2): 441-51.doi: 10.2147/tcrm.s1964.
3. Bryna Harwood Contraceptive Vaginal Rings the global library of women’s medicine’s welfare of women global health program (ISSN: 1756-2228) 2008; DOI 10.3843/GLOWM.10396 https://www.glowm.com/section-view/heading/Contraceptive%20Vaginal%20Rings/item/ 395#.Yeg31PLhWDY.
4. Griffin B, Ridgeway K, Montgomery E. Vaginal ring acceptability and related preferences among women in low- and middle-income countries: A systematic review and narrative synthesis. 2019 Nov 8; PLoS ONE 14(11): e0224898. https:// doi.org/10.1371/ journal. pone.0224898
5. Céline Schurmans1, Irith De Baetselier, Evelyne Kestelyn A Study to A The ring plus project: safety and acceptability of vaginal rings that protect women from unintended pregnancy. BMC Public Health 2015; 15: 348. DOI 10.1186/s12889-015-1680-y.
6. Sara E. Vargas, Miriam M. Midoun, Melissa Guillen A Study to A Qualitative Systematic Review of Women’s Experiences Using Contraceptive Vaginal Rings: Implications for New Technologies, Guttmacher Institute is collaborating with JSTOR to digitize, preserve and extend access to International Perspectives on Sexual and Reproductive Health, 2019; 45: 25–34, doi:10.1363/45e7619.
7. Frans J. M. E. Roumen∗ and Daniel R. Mishell Jr A Study to AThe contraceptive vaginal ring, NuvaRing (R), a decade after its introduction. Article in The European Journal of Contraception and Reproductive Health Care · 2012Oct; DOI: 10.3109/13625187.2012.713535.
8. Prescription NuvaRing is a flexible birth controlvaginal ring used to prevent pregnancy https://www.nuvaring.com/safety-information/.
9. F J Roumen1, D Apter, T M Mulders, T O Dieben. Efficacy, tolerability and acceptability of a novel contraceptive vaginal ring releasing etonogestrel and ethinyloestradiol. National Center for Biotechnology Information journal. 2001 Mar 16; (3): 469-75.doi: 10.1093/humrep/16.3.469.